Influence of low calcium dialysate calcium on calcium and phosphorus metabolism and parathyroid hormone in patients with maintenance hemodialysis
-
摘要: 目的 探讨低钙透析液对非低钙血症维持性血液透析患者的钙磷代谢以及甲状旁腺激素的影响.方法 将60例非低钙血症维持性血液透析患者随机分为观察组与对照组,观察组采用低钙透析液(Ca2浓度为1.25 mmol/L),对照组采用常规透析液(C a2+浓度为1.50 mmol/L),比较2组患者的疗效.结果 治疗后,观察组患者血清T-Ca、T-Ca×P显著下降,血清iPTH显著升高(P＜0.05);对照组患者血清T-Ca、T-Ca×P显著升高,血清iPTH显著下降(P＜0.05).观察组患者血清T-Ca、T-Ca×P均显著低于对照组,血清iPTH均显著高于对照组(P＜0.05).治疗6个月后,观察组患者血清hs-CRP显著低于对照组(P＜0.05).2组患者不良反应发生率无显著差异(P＞0.05).结论 非低钙血症维持性血液透析患者应用低钙透析液可以降低血清高钙负荷,改善甲状旁腺过度抑制状态与心血管炎症状态.Abstract: Objective To explore the effect of low calcium dialysate on calcium and phosphorus metabolism and parathyroid hormone in patients with maintenance hemodialysis.Methods A total of 60 non-hypocalcemia patients with maintenance hemodialysis were randomly divided into observation group and control group.The observation group was treated with low calcium dialysate (Ca2 + concentration was 1.25 mmol/L),while the control group was treated with conventional calcium dialysate (Ca2 + concentration was 1.50 mmol/L).Effect was compared between two groups.Results After treatment,the serum T-Ca,T-Ca × P significantly decreased in the observation group,and serum iPTH significantly increased (P ＜ 0.05).In the control group,the serum T-Ca,T-Ca x P significantly increased,and serum iPTH decreased significantly (P ＜ 0.05).The serum levels of TCa,T-Ca x P in the observation group were significantly lower than those in the control group,and the serum iPTH level was significantly higher than that in the control group (P ＜ 0.05).After 6 months of treatment,the serum hs-CRP level of the observation group was significantly lower than that of the control group (P ＜ 0.05).There was no significant difference in the incidence rate of adverse reactions between the two groups (P ＞ 0.05).Conclusion Application of low calcium dialysate can decrease serum high calcium loading,improve the status of excessive inhibition of parathyroid hormone and cardiovascular inflammation status in treatment of non-hypocalcemia patients with maintenance hemodialysis.
-
-
期刊类型引用(12)
1. 李志龙，陈斯韵，魏晓萍. 维持性血液透析患者钙磷代谢异常危险因素与干预措施分析. 临床合理用药杂志. 2021(18): 27-29 . 
百度学术
2. 王利娟，梁巧静，孙晓媚，陈燊. 碳酸镧联合低钙透析对高龄维持性血液透析患者钙磷代谢和全段甲状旁腺激素的影响. 中国医院用药评价与分析. 2021(08): 959-962 . 百度学术
3. 郑建国，郑栓，王东海. 低钙腹膜透析液对慢性肾功能衰竭患者血清钙磷代谢及肾功能的影响. 中国实用医刊. 2021(17): 86-89 . 百度学术
4. 叶晓燕. 血液透析治疗糖尿病肾病与慢性肾小球肾炎的临床研究. 现代医学与健康研究电子杂志. 2021(22): 133-136 . 百度学术
5. 周璐祎. 降低透析液钙浓度对维持性血液透析患者慢性肾脏病-矿物质骨代谢异常的应用效果. 河南医学研究. 2020(21): 3875-3877 . 百度学术
6. 廖琳，路建饶，陈杰，陈晛，胡静，张传富，韩海燕，郭玥. 不同钙浓度透析液在老年MHD伴动力缺失性肾性骨病患者治疗中的效果差异. 标记免疫分析与临床. 2020(09): 1487-1490+1541 . 百度学术
7. 黄盈. 低钙透析对维持性血液透析患者钙磷代谢及甲状旁腺激素影响的Meta分析. 中国血液净化. 2019(01): 21-25 . 百度学术
8. 朱雪丽，苏东美，陈治宇，温月. 盐酸司维拉姆与低钙透析液合用对血液透析患者相关血清指标的改善效果. 武警医学. 2019(02): 101-104 . 百度学术
9. 李芸，胡天晓，郑朝霞，段丽萍，张志青. 高通量透析联合低钙透析液对维持性血液透析患者甲状旁腺激素及钙磷代谢的影响. 解放军医药杂志. 2019(09): 51-55 . 百度学术
10. 刘力君. 不同透析方式对尿毒症患者钙磷代谢影响的临床效果及有效率影响分析. 世界复合医学. 2019(09): 35-38 . 百度学术
11. 刘刚. 腹膜透析继发甲状旁腺功能亢进患者综合治疗的临床观察. 人人健康. 2018(02): 82-83 . 百度学术
12. 陈金，任郁，黄群. 血液净化方式控制维持性血液透析患者血磷及甲状旁腺素的临床应用效果对比. 吉林医学. 2018(11): 2043-2044 . 百度学术
其他类型引用(0)
计量
- 文章访问数: 357
- HTML全文浏览量: 57
- PDF下载量: 4
- 被引次数: 12
下载:
苏公网安备 32100302010246号